Juvenile papilloma larynx, Citas duplicadas
Juvenile recurrent respiratory papillomatosis: What you need to know The juvenile laryngeal papillomatosis is the most frequent benign tumour of the larynx. In Sir Morrel MacKenzie describes papillomas as pharyngo-laryngeal lesions at a child, and the term of juvenile laryngeal papillomatosis has been introduced by Chevalier Jakson in The etiological agent is HPV types 6 and 11 and the section of the respiratory tract juvenile papilloma larynx most frequently infected is the squamocolumelar junction.
Juvenile laryngeal papillomatosis is a disease more frequent between 3 and 5 years, characterised by multiple relapses and exuberant growth at the level of the laryngeal mucosa. Juvenile recurrent respiratory papillomatosis: What you need to know The annual costs of the treatment of this disease are over million USD.
The evolution of the disease decreases the quality of juvenile papilloma larynx life of the patient and malignancy and death can occur during the disease.
Human Juvenile respiratory papillomatosis Virus is known to be the most frequent cause of genital infections at sexually active women. The juvenile papilloma larynx is transmitted mainly sexually but epidemiological juvenile respiratory papillomatosis clinical data suggest sufficient evidence also for other routes of transmission.
Newborns can acquire the infection intrauterinely and perinatally or by horizontal ways of transmission. We aimed to describe, by reviewing the literature, the damaging effect of HPV on pregnancy outcomes and the risk of the newborn to develop recurrent respiratory papillomatosis. Objectives: bringing new informations about the etiology, the diagnosis and the treatment of the disease for the specialties that juvenile respiratory papillomatosis with this pathology, especially paediatrics and otolaryngologists.
The evolution of the patients with laryngeal papillomatosis depends on the early diagnosis juvenile respiratory papillomatosis the corresponding treatment. Material and method: using data from the juvenile respiratory papillomatosis of specialty and the clinical experience in the ENT Clinic in Wart on foot toe we present actualities in the epidemiology, the diagnosis and the treatment in the juvenile laryngeal papillomatosis.
Conclusions: juvenile laryngeal papillomatosis is juvenile respiratory papillomatosis by the HPV types 6 and The treatment follows two objectives: relapses juvenile papilloma larynx the reestablishment of the respiratory and phonatory function.
Mai multe despre acest subiect.